VYNE Therapeutics Inc. (VYNE) › Shares OutstandingVYNE Therapeutics Inc. (VYNE) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2016: 5.28M2017: 5.30M2018: 23.23M2019: 9.12M2020: 43.21M2021: 2.98M2022: 3.23M2023: 14.10M2024: 14.83M2025: 33.32M33.32M2016Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202533.32M+124.7%202414.83M+5.2%202314.10M+336.5%20223.23M+8.5%20212.98M-93.1%202043.21M+373.7%20199.12M-60.7%201823.23M+338.5%20175.30M+0.4%20165.28M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share